Personalised dietary strategies are particularly relevant considering that, although generally well tolerated, GLP-1RA may cause transient gastrointestinal (GI) symptoms that can hinder adherence if not properly managed [27]
All you need is a smartphone, computer, or tablet to consult with our expert semaglutide providers
These compounded preparations are subject to different regulatory standards than FDA-approved manufactured drugs
Depending on the formula, both semaglutide and tirzepatide medications are FDA-approved for either weight loss or type 2 diabetes treatment
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Always consider these options